Kelly Comma

Kelly Comma, ALB, MSL, is an experienced executive assistant currently serving as the Executive Assistant to the Chief Innovation Officer and Chief Scientific Officer at Dyne Therapeutics since August 2021. Prior roles include supporting the Chief Operating Officer at Dana-Farber Cancer Institute, where responsibilities encompassed managing complex scheduling and being a key contact for stakeholders. Kelly has also held positions as Executive Administrator at Cambrian Innovation, Attorney Development Specialist at Ropes & Gray LLP, and Executive Assistant at Brigham and Women's Hospital, showcasing a strong background in administrative support and project coordination across various sectors. Earlier experience includes roles in admissions at ITT Educational Services and Apollo Education Group, contributing to recruitment and student retention. Kelly holds a Bachelor of Liberal Arts from Harvard University, a Master of Science in Law from Champlain College, and is currently pursuing a PhD in Social Psychology at Liberty University.